ARTICLE | Clinical News
Zostavax regulatory update
February 27, 2006 8:00 AM UTC
FDA extended the PDUFA date for a BLA for Zostavax zoster vaccine by 3 months to May 25 from Feb. 23 to allow for review of additional undisclosed information submitted by MRK. The company is seeking ...